C57BL/6N-Irgm1em1(IMPC)Wtsi/WtsiCnbc

Status

Available to order

EMMA IDEM:14780
International strain nameC57BL/6N-Irgm1em1(IMPC)Wtsi/WtsiCnbc
Alternative name
Strain typeEndonuclease-mediated
Allele/Transgene symbolIrgm1em1(IMPC)Wtsi
Gene/Transgene symbolIrgm1

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous C57BL/6N

Disease and phenotype information

IMPC phenotypes (allele matching)
  • increased circulating LDL cholesterol level / IMPC
  • decreased hematocrit / IMPC
  • abnormal eye morphology / IMPC
  • increased mean platelet volume / IMPC
  • decreased hemoglobin content / IMPC
  • decreased erythrocyte cell number / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • thrombocytopenia / IMPC
  • increased lean body mass / IMPC
  • increased circulating cholesterol level / IMPC
  • improved glucose tolerance / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • decreased circulating serum albumin level / IMPC
  • decreased circulating glucose level / IMPC
  • increased red blood cell distribution width / IMPC
  • decreased circulating fructosamine level / IMPC
  • decreased fasting circulating glucose level / IMPC
IMPC phenotypes (gene matching)
  • increased circulating aspartate transaminase level / IMPC
  • increased lean body mass / IMPC
  • decreased circulating glucose level / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • decreased erythrocyte cell number / IMPC
  • increased red blood cell distribution width / IMPC
  • improved glucose tolerance / IMPC
  • decreased circulating fructosamine level / IMPC
  • decreased hemoglobin content / IMPC
  • thrombocytopenia / IMPC
  • abnormal eye morphology / IMPC
  • decreased fasting circulating glucose level / IMPC
  • decreased circulating serum albumin level / IMPC
  • increased mean platelet volume / IMPC
  • increased circulating LDL cholesterol level / IMPC
  • decreased hematocrit / IMPC
  • increased circulating cholesterol level / IMPC

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).